Detalhe da pesquisa
1.
A broad and potent neutralization epitope in SARS-related coronaviruses.
Proc Natl Acad Sci U S A
; 119(29): e2205784119, 2022 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35767670
2.
Prophylactic Administration of the Monoclonal Antibody Adintrevimab Protects against SARS-CoV-2 in Hamster and Non-Human Primate Models of COVID-19.
Antimicrob Agents Chemother
; 67(1): e0135322, 2023 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36519929
3.
Evolution of antibody immunity following Omicron BA.1 breakthrough infection.
Nat Commun
; 14(1): 2751, 2023 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37173311
4.
Characteristics and functions of infection-enhancing antibodies to the N-terminal domain of SARS-CoV-2.
bioRxiv
; 2023 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37786672
5.
Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers.
Sci Transl Med
; 15(688): eadg2783, 2023 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36947596
6.
Recall of preexisting cross-reactive B cell memory after Omicron BA.1 breakthrough infection.
Sci Immunol
; 7(73): eabq3511, 2022 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35549299
7.
Human antibodies to SARS-CoV-2 with a recurring YYDRxG motif retain binding and neutralization to variants of concern including Omicron.
Commun Biol
; 5(1): 766, 2022 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35906394
8.
Broad anti-SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 vaccination.
Science
; 375(6584): 1041-1047, 2022 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35143256
9.
Evolution of antibody immunity following Omicron BA.1 breakthrough infection.
bioRxiv
; 2022 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36172124
10.
A broad and potent neutralization epitope in SARS-related coronaviruses.
bioRxiv
; 2022 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35313576
11.
Revisiting an IgG Fc Loss-of-Function Experiment: the Role of Complement in HIV Broadly Neutralizing Antibody b12 Activity.
mBio
; 12(5): e0174321, 2021 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34634936
12.
Prolonged evolution of the human B cell response to SARS-CoV-2 infection.
Sci Immunol
; 6(56)2021 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33622975
13.
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody.
Science
; 371(6531): 823-829, 2021 02 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33495307
14.
An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19.
bioRxiv
; 2020 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33236009